Blood markers for predicting infection and survival in sepsis patients
Part of Infections clinical trials.
This trial checks if certain blood markers (CRP, CRP/albumin ratio, and neutrophil/lymphocyte ratio) can predict how well sepsis patients with normal blood pressure will do. It aims to help doctors better manage infections and survival.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have sepsis with normal blood pressure.
- You cannot have used corticosteroids or antibiotics before admission to the hospital.
- You cannot have a blood disorder or cancer.
- You cannot have had chemotherapy or radiation therapy in the last month.
- You cannot have shock.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two blood test measurements (neutrophil/lymphocyte ratio and lactate/albumin ratio) to see which better predicts how severe an infection is in ICU patients with sepsis. It aims to find a simpler way to track inflammation.
This study looks at blood test “markers” to tell the difference between infection and non-infectious illness. It may help doctors recognize infection earlier and avoid confusion with other conditions.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
This study checks if a simple blood flow measurement can help predict which patients with sepsis are at higher risk of dying within 28 days. The goal is to see if this test can guide treatment decisions in the ICU.
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
This trial is testing whether certain biomarkers (substances in your body) can help diagnose sepsis faster. Sepsis is a serious condition where your body has a severe response to an infection. The study will look at blood or other samples to see if these markers can quickly tell if you have sepsis, which could lead to faster treatment.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.